(a) Schematic of ovalbumin (PDB code 1ova) antigen conjugation to barcoded DNA with phosphodiester and phosphorothioate DNA linkages and a 3′ biotin label (circle with B inside). Sulfur replaces a …
Antigen tags and other oligonucleotide sequences used in qPCR and single-cell experiments.
(a) Gating and single-color staining controls for anti-ovalbumin (ova) and streptavidin 1 day post addition of ova-psDNA. (b) Flow cytometry of SV-40 transformed endothelial cells (SVEC) with …
(a) Bone marrow- derived dendritic cells (BMDCs) were grown for 7 days and cultured in GM-CSF. After 7 days, 5 mg of either pDNA, psDNA, ova-pDNA, or ova-psDNA were added to the culture media, and …
(a) Mice were immunized in the footpad with ovalbumin (ova) alone or ova-psDNA with or without polyI:C/aCD40 or polyI:C. After 7 days, draining popliteal lymph nodes (LNs) were harvested and cells …
(a) Gating strategy for tetramer staining and intracellular cytokine staining of CD8 T cells. (b) Gating strategy used for cell sorting prior to single-cell RNA sequencing.
(a) Mice were vaccinated in the footpad with 10 µg of ova-pDNA (phosphodiester backbone) or ova-psDNA (phosphorothioate backbone) with or without vaccinia virus (103 PFU). Each barcode conjugate …
(a, d, g, j) Uniform manifold approximation and projections (UMAPs) are shown for dendritic cells (DCs) (a, d), lymphatic endothelial cells (LECs) (g), and fibroblastic reticular cells (FRC)s (j) at …
Comparison of relative ovalbumin (ova) signal for cell types shown in Figure 3—figure supplements 3, 4b, and 5b.
A two-sided Wilcoxon rank-sum test was used to compare relative ova signal for each cell type. Relative ova signal was calculated by dividing antigen counts for each cell by the median antigen counts for T and B cells. The Bonferroni method was used to correct for multiple comparisons. The number of cells in each group (n cells), fraction of the total cells for the sample (frac cells), median relative ova signal, test statistic (statistic), estimation of the median difference (estimate), and confidence interval (conf.low, conf.high) are included.
Mice were vaccinated with ova-psDNA, psDNA, and pDNA with IE3 CFU of VV-WR. Each DNA injected had a unique barcode sequence for detection during sequencing. Counts of ova-psDNA, psDNA, and pDNA for …
Antigen counts were compared with total mRNA counts for each cell for dendritic cells (DCs) (a, b), lymphatic endothelial cells (LECs) (c, d), and FRCs (e, f). Pearson’s correlation coefficient and …
(a) A uniform manifold approximation and projection (UMAP) is shown for LEC types, epithelial cells, B cells and T cells identified for the day 2 time point. (b) Relative ovalbumin (ova) signal is …
(a) Gating strategy for LECs in the dLN with markers for ICAM1 and PD-L1. (b) Representative flow plots of antigen held by LECs 14 days following subcutaneous immunization with OVA488 (10 μg/site), …
(a) Uniform manifold approximation and projection (UMAP) is shown for FRC cell types, B cells, and T cells identified for the day 2 time point. (b) Relative ovalbumin signal is shown for each cell …
(a, e) Day 2 (a) and day 14 (e) cDC2 Tbet- cells containing low and high antigen counts were identified using a two-component mixture model. A uniform manifold approximation and projection (UMAP) is …
Genes associated with ovalbumin (ova)-high cells for dendritic cell (DC), FRC, and lymphatic endothelial cell (LEC) subtypes.
Ova-low and ova-high cells were independently identified for each cell type shown in Figure 3 using a Gaussian mixture model implemented with the R package mixtools. Differentially expressed genes were identified using a Wilcoxon rank-sum test performed using the R package presto (wilcoxauc). The Benjamini–Hochberg method was used to correct for multiple comparisons. Genes were filtered to only include those with an adjusted p-value<0.05, log fold-change >0.25, area under the receiver operator curve (AUC) >0.5, and with at least 50% of ova-high cells expressing the gene. The average expression, log fold-change, test statistic (statistic), AUC, percentage of ova-high cells that express the gene (pct_in), and percentage of ova-low cells that express the gene (pct_out) are included.
(a) Day 14 LECs were classified into antigen-high and antigen-low using a two-component Gaussian mixture model. A uniform manifold approximation and projection (UMAP) is shown for antigen-low and …
Genes associated with ovalbumin (ova)-low and ova-high cells for dendritic cells (DCs), FRCs, and lymphatic endothelial cells (LECs).
Ova-low and ova-high cells were identified independently for DCs, FRCs, and LECs using a Gaussian mixture model implemented with the R package mixtools. Differentially expressed genes were identified as described for Figure 4—source data 1.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Antibody | Anti-mouse CD40 (Rat monoclonal) | BioXcell | Cat#BE0016-2 | |
Antibody | Anti-ovalbumin (rabbit monoclonal) | Abcam | Ab181688 | 1:100 |
Antibody | Anti-rabbit IgG PE (Donkey polyclonal) | Biolegend | Cat# 406421 RRID:AB_2563484 | 1:100 |
Antibody | Anti-mouse CD45 BV510 (Rat monoclonal) | Biolegend | Cat#103138 RRID:AB_2563061 | 1:300 |
Antibody | Anti-mouse CD45 PE (Rat monoclonal) | Biolegend | Cat#103106 RRID:AB_312971 | 1:300 |
Antibody | Anti-mouse podoplanin APC (Hamster monoclonal) | Biolegend | Cat#127410 RRID:AB_10613649 | 1:200 |
Antibody | Anti-mouse CD31 PerCP-Cy5.5 (Rat monoclonal) | Biolegend | Cat#102420 RRID:AB_10613644 | 1:200 |
Antibody | Anti-mouse PD-L1 BV421 (Rat monoclonal) | Biolegend | Cat#124315 RRID:AB_10897097 | 1:200 |
Antibody | Anti-mouse CD8a APC-Cy7 (Rat monoclonal) | Biolegend | Cat#100714 RRID:AB_312753 | 1:400 |
Antibody | Anti-mouse CD44 PerCP-Cy5.5 (Rat monoclonal) | Biolegend | Cat# 103032 RRID:AB_2076204 | 1:400 |
Antibody | Anti-mouse B220/CD45R BV510 (Rat monoclonal) | Biolegend | Cat# 103248 RRID:AB_2650679 | 1:300 |
Antibody | Anti-mouse B220/CD45R PE (Rat monoclonal) | Biolegend | Cat# 103208 RRID:AB_312993 | 1:300 |
Antibody | Anti-mouse CD11c APC Cy7 (Hamster monoclonal) | Biolegend | Cat#117324 RRID:AB_830649 | 1:400 |
Antibody | Anti-mouse CD11b PE-Cy7 (Rat monoclonal) | Biolegend | Cat#101216 | 1:300 |
Peptide, recombinant protein | Streptavidin BV421 | Biolegend | Cat#405226 | 1:1000 |
Peptide, recombinant protein | Streptavidin AF488 | Thermo Fisher Scientific | Cat#S11223 | 1:1000 |
Chemical compound, drug | PolyI:C | Invivogen | Cat#Vac-PIC | |
Chemical compound, drug | Nystatin | Sigma Aldrich | Cat#N4014 | |
Chemical compound, drug | Violet proliferation dye | BD Biosciences | Cat#562158 | |
Chemical compound, drug | CFSE | BD Biosciences | Cat#565082 | |
Strain, strain background (Mus musculus) | WT: C57BL/6 | Charles River Labs | C57BL/6 (B6) Mouse Inbred 027 | |
Strain, strain background (M. musculus) | OT1: C57BL/6-Tg(TcraTcrb) 1100Mjb/J | Jackson Labs | JAX: 003831 | |
Cell line (M. musculus) | SVEC4-10 | ATCC | ATCC CRL2181 | |
Primary cells (M. musculus) | mLEC | Cell Biologics | C57-6092 |